ALFA FinderBSE filing, NSE: BLISSGVS. Summary written from the filing by ALFA Finder's alert engine.
Bliss GVS Pharma Ltd: key numbers
- Share price
- ₹614.25
- Market cap
- ₹6,535 Cr
- Revenue (annual)
- ₹927.1 Cr
- Net profit (annual)
- ₹129.1 Cr
- P/E (TTM)
- 40.5×Sector 43.0×
- Promoter holding
- 50.07%+15.06% QoQ
- FII holding
- 5.03%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Bliss GVS Pharma Ltd
All →Bliss GVS Pharma Legal & Regulatory
Bliss GVS Pharma was fined Rs. 1,80,000 (excluding GST) by BSE and NSE for failing to appoint a woman director. The fine has been paid to the regulators.
- Value
- ₹0.02 Cr
- From
- BSE Limited and National Stock Exchange of India Limited
Bliss GVS Pharma Regulatory Approval
Bliss GVS Pharma's UK subsidiary Asterisk Lifesciences received MHRA marketing authorisation for Mesalazine 1g Suppositories. The approval lets the subsidiary market the product in the UK.
Bliss GVS Pharma Q2 FY27 Results: Net Profit ₹53.3 Cr, Up 86.4% YoY
Bliss GVS Pharma Ltd reported revenue from operations of ₹313.4 Cr (+28.2% YoY) and net profit of ₹53.3 Cr (+86.4% YoY) for Q2 FY27.
- Key figure
- Net profit ₹53.3 Cr · +86.4% YoY
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bliss GVS Pharma Board Meeting Date
Bliss GVS Pharma Ltd scheduled a board meeting for October 29, 2026, to approve the company's unaudited financial results for the quarter ending September 30, 2026.
Bliss GVS Pharma Other Announcement
Bliss GVS Pharma Ltd has filed its quarterly shareholding pattern report for the period ended September 30, 2026.
Other financial results announcements
All →Velox Shipping and Logistics Q2 FY27 Results: Net Profit ₹0.8 Cr, Up 166.7% YoY
Velox Shipping and Logistics Ltd reported revenue from operations of ₹2.5 Cr and net profit of ₹0.8 Cr (+166.7% YoY) for Q2 FY27.
- Key figure
- Net profit ₹0.8 Cr · +166.7% YoY
Ecofinity Atomix Q2 FY27 Results: Net Profit ₹0.7 Cr, Up 16.7% YoY
Ecofinity Atomix Ltd reported revenue from operations of ₹26.5 Cr (+145.4% YoY) and net profit of ₹0.7 Cr (+16.7% YoY) for Q2 FY27.
- Key figure
- Net profit ₹0.7 Cr · +16.7% YoY
Transglobe Foods Q2 FY27 Results: Net Profit ₹0 Cr
Transglobe Foods reported unaudited Q2 and H1 FY27 results for the period ended 30 September 2026. The half-year net loss was ₹3.49 lakhs, with going-concern doubts noted.
- Key figure
- Net profit ₹0 Cr
Euro India Fresh Foods Q2 FY27 Results: Turns Profitable, Net Profit ₹0.1 Cr
Euro India Fresh Foods Ltd reported revenue from operations of ₹29.9 Cr (-8.0% YoY) and net profit of ₹0.1 Cr for Q2 FY27.
- Key figure
- Net profit ₹0.1 Cr
Market Creators Q2 FY27 Results: Turns Profitable, Net Profit ₹0.1 Cr
Market Creators Ltd reported revenue from operations of ₹1.4 Cr (+16.7% YoY) and net profit of ₹0.1 Cr for Q2 FY27.
- Key figure
- Net profit ₹0.1 Cr
Sharma East India Hospitals & Medical Research Q2 FY27 Results: Net Profit ₹0.3 Cr, Up 0.0% YoY
Sharma East India Hospitals & Medical Research Ltd reported revenue from operations of ₹10.4 Cr (+10.6% YoY) and net profit of ₹0.3 Cr (+0.0% YoY) for Q2 FY27.
- Key figure
- Net profit ₹0.3 Cr · +0.0% YoY